Gergely Szakács

12.1k total citations · 2 hit papers
141 papers, 9.8k citations indexed

About

Gergely Szakács is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Gergely Szakács has authored 141 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Oncology, 65 papers in Molecular Biology and 24 papers in Infectious Diseases. Recurrent topics in Gergely Szakács's work include Drug Transport and Resistance Mechanisms (84 papers), HIV/AIDS drug development and treatment (22 papers) and Metal complexes synthesis and properties (21 papers). Gergely Szakács is often cited by papers focused on Drug Transport and Resistance Mechanisms (84 papers), HIV/AIDS drug development and treatment (22 papers) and Metal complexes synthesis and properties (21 papers). Gergely Szakács collaborates with scholars based in Hungary, Austria and United States. Gergely Szakács's co-authors include Michael M. Gottesman, Joseph A. Ludwig, Catherine Booth-Genthe, Balázs Sarkadi, András Váradi, Csilla Özvegy‐Laczka, László Homolya, Veronika F.S. Pape, Éva Bakos and John N. Weinstein and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Gergely Szakács

135 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting multidrug resistance in cancer

2006 3.0k citations Gergely Szakács, Joseph A. Ludwig et al. profile →
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System

2006 592 citations Balázs Sarkadi, László Homolya et al. Physiological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gergely Szakács Hungary	43	6.0k	4.7k	1.1k	1.0k	948	141	9.8k
Robert W. Robey United States	62	9.2k 1.5×	7.3k 1.6×	2.3k 2.0×	1.6k 1.6×	538 0.6×	159	13.8k
Antonio Tito Fojo United States	48	8.4k 1.4×	6.9k 1.5×	1.3k 1.2×	1.0k 1.0×	379 0.4×	137	13.6k
Olaf van Tellingen Netherlands	64	10.0k 1.6×	5.3k 1.1×	3.8k 3.3×	1.0k 1.0×	341 0.4×	238	16.1k
Liwu Fu China	53	4.9k 0.8×	5.4k 1.2×	409 0.4×	609 0.6×	826 0.9×	209	9.9k
Douglas D. Ross United States	41	5.5k 0.9×	4.2k 0.9×	1.6k 1.4×	906 0.9×	301 0.3×	99	8.5k
Kees Nooter Netherlands	52	5.4k 0.9×	3.9k 0.8×	960 0.8×	609 0.6×	428 0.5×	149	9.1k
T Tsuruo Japan	49	5.6k 0.9×	5.4k 1.2×	1.3k 1.2×	796 0.8×	508 0.5×	155	9.7k
Kenneth K.W. To Hong Kong	48	3.2k 0.5×	4.0k 0.9×	394 0.3×	388 0.4×	508 0.5×	164	7.5k
Branimir I. Šikić United States	57	4.9k 0.8×	4.7k 1.0×	872 0.8×	557 0.5×	303 0.3×	225	9.6k
Peter W. Swaan United States	44	2.2k 0.4×	2.9k 0.6×	792 0.7×	363 0.4×	631 0.7×	129	6.9k

Countries citing papers authored by Gergely Szakács

Since Specialization

Citations

This map shows the geographic impact of Gergely Szakács's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gergely Szakács with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gergely Szakács more than expected).

Fields of papers citing papers by Gergely Szakács

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gergely Szakács. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gergely Szakács. The network helps show where Gergely Szakács may publish in the future.

Co-authorship network of co-authors of Gergely Szakács

This figure shows the co-authorship network connecting the top 25 collaborators of Gergely Szakács. A scholar is included among the top collaborators of Gergely Szakács based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gergely Szakács. Gergely Szakács is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Füredi, András, et al.. (2025). Tumor Model Fitting using Markov Chain Monte Carlo Method. Acta Polytechnica Hungarica. 22(12). 183–196.

2.

Szakács, Gergely, et al.. (2024). Strain‐Release‐Driven Modular Synthesis of Oxetane‐Based Amide Bioisosteres: Concise, Robust and Scalable Approach. Angewandte Chemie International Edition. 63(42). e202410554–e202410554. 3 indexed citations

3.

Szakács, Gergely, et al.. (2024). Strain‐Release‐Driven Modular Synthesis of Oxetane‐Based Amide Bioisosteres: Concise, Robust and Scalable Approach. Angewandte Chemie. 136(42). 1 indexed citations

4.

Jakusch, Tamás, et al.. (2024). Complex formation of ML324, the histone demethylase inhibitor, with essential metal ions: Relationship between solution chemistry and anticancer activity. Journal of Inorganic Biochemistry. 255. 112540–112540.

5.

Erdei, Zsuzsa, Edit Szabó, György Várady, et al.. (2024). Mesenchymal Stem Cells Increase Drug Tolerance of A431 Cells Only in 3D Spheroids, Not in 2D Co-Cultures. International Journal of Molecular Sciences. 25(8). 4515–4515. 1 indexed citations

6.

Molnár, Adrienn, Nóra Kucsma, James S. McKenzie, et al.. (2024). Characterisation of Canine and Feline Breast Tumours, Their Metastases, and Corresponding Primary Cell Lines Using LA-REIMS and DESI-MS Imaging. International Journal of Molecular Sciences. 25(14). 7752–7752. 4 indexed citations

7.

Mocsár, Gábor, Thomas Stockner, László Homolya, et al.. (2023). Nucleotide binding is the critical regulator of ABCG2 conformational transitions. eLife. 12. 10 indexed citations

8.

Bongers, Brandon J., Ulf Norinder, Gergely Szakács, et al.. (2022). Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening. Journal of Chemical Information and Modeling. 62(24). 6323–6335. 20 indexed citations

9.

Bagi, Péter, Szilárd Tóth, Gergely Szakács, et al.. (2022). Efficient Synthesis of Acylated, Dialkyl α-Hydroxy-Benzylphosphonates and Their Anticancer Activity. Molecules. 27(7). 2067–2067. 4 indexed citations

10.

Mayer, Balázs, Sarolta Kárpáti, Éva Mezey, et al.. (2021). Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner. Cancers. 13(24). 6173–6173. 8 indexed citations

11.

Tóth, Szilárd, Viet‐Khoa Tran‐Nguyen, Balázs Sarkadi, et al.. (2020). Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance. Molecules. 25(3). 764–764. 20 indexed citations

12.

Szakács, Gergely & Rupert Abele. (2020). An inventory of lysosomal ABC transporters. FEBS Letters. 594(23). 3965–3985. 46 indexed citations

13.

Cserepes, Mihály, Dóra Türk, Szilárd Tóth, et al.. (2019). Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein–Expressing Cells. Cancer Research. 80(4). 663–674. 29 indexed citations

14.

Rádai, Zita, Véronika Nagy, András Füredi, et al.. (2019). Synthesis and anticancer cytotoxicity with structural context of an α-hydroxyphosphonate based compound library derived from substituted benzaldehydes. New Journal of Chemistry. 43(35). 14028–14035. 16 indexed citations

15.

Tóth, Szilárd, István Szabadkai, Ferenc Baska, et al.. (2018). Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters. PLoS ONE. 13(9). e0202749–e0202749. 6 indexed citations

16.

Füredi, András, Szilárd Tóth, Kornélia Szebényi, et al.. (2016). Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity. Molecular Cancer Therapeutics. 16(1). 45–56. 41 indexed citations

17.

Türk, Dóra, Matthew D. Hall, Benjamin F. Chu, et al.. (2009). Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells. Cancer Research. 69(21). 8293–8301. 87 indexed citations

18.

Okabe, Mitsunori, Gergely Szakács, Mark A. Reimers, et al.. (2008). Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Molecular Cancer Therapeutics. 7(9). 3081–3091. 124 indexed citations

19.

Sarkadi, Balázs, László Homolya, Gergely Szakács, & András Váradi. (2006). Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System. Physiological Reviews. 86(4). 1179–1236. 592 indexed citations breakdown →

20.

Bakos, Éva, Raymond Evers, Giulia Calenda, et al.. (2000). Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). Journal of Cell Science. 113(24). 4451–4461. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact